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Identification and action of several antibacterial metabolites produced by a fish pathogen Vibrio 
parahaemolyticus strain An3 from marine ecosystem of Goa has been demonstrated. Antibacterial 
activity of the crude cell extract of the test bacterium has been evaluated against indicator pathogenic 
bacterial strains such as Acinetobacter sp. An2, Aeromonas hydrophila strain An4, Staphylococcus 
arlettae strain An1 and Alteromonas aurentia strain SE3 by agar well diffusion method which clearly 
demonstrated comparatively more significant inhibitory effect on indicator bacteria as compared to 
several commonly used antibiotics. Gas chromatography mass spectrometry (GC-MS) analysis of crude 
cell extract of the test organism interestingly revealed presence of indole, phenyl acetic acid, n-(3-
methyl-1, 2, 4-oxadiazol-5-yl) - 1- pyrrolidine carboximidamide, pyrrolopyrazines, tetramethyl pyrazine 
and other important phenolic compounds which may be responsible for antibacterial activity against 
indicator microorganisms tested. It has been clearly demonstrated that V. parahaemolyticus strain An3 
produced several medically important organic metabolites during cultivation suggesting it as a 
potential candidate for production of several antibacterial metabolites to control pathogenic bacterial 
strains causing serious fish and human diseases. 
 






There is an increasing demand of therapeutic drugs from 
diverse natural resources. After many years of extensive 
research, the importance of terrestrial bacteria as source 
of valuable bioactive compounds has been very well 
established and exploited. As a result, the ocean and 
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microorganisms have now become the main focus of 
drug discovery research (Finical, 1993).These studies are 
concerned with bacteria and fungi isolated from sea 
water, sediments, invertebrates and fish (Kelecom, 2002). 
Bacteria occurring in aquatic ecosystems may have the 
ability to inhibit the growth of other microorganisms by 
producing antimicrobial substances such as antibiotics 
and bacteriocins. Their inhibitory mechanisms include: (i) 
Production of antibiotics, bacteriocins, siderophores, 
lysozymes, and proteases and (ii) alteration of pH through 
production of organic acids (Jorquera et al., 1999). 
Vibrio spp. are common inhabitants of aquatic environ-
ment and are found free living as well as associated with 
various marine organisms such as squids, shrimps, 
corals, fish, molluscs, seagrasses and sponges. Some 
species are found as symbionts in specialized luminous 
organs of marine fish and invertebrates, whereas a number 






marine animals (Thompson et al., 2004). Vibrio 
paraheamolyticus is one of the leading pathogens causing 
fish and human diseases. Recently, several biologically 
active substances have been isolated from marine 
bacteria. There are many reports about antibacterial activity 
shown by marine bacteria; Pseudomonas, Yersinia, 
Aeromonas, Brevibacterium, Bacillus and Alteromonas 
(Gauthier and Breittmayer, 1979; Shiozawa et al., 1997; 
Jorquera et al., 1999; Khalil et al., 2006; Ahmed et al., 
2008; Rahman et al., 2010). There are few reports on 
vibrios producing antimicrobial substances (Sugita et al., 
1997; Long and Azam, 2001; Castro et al., 2002; Hjelm et 
al., 2004; Norhana and Darah, 2005). In our investigation 
we have reported organic metabolites of a fish pathogenic 
strain of V. parahaemolyticus which inhibited the growth 
of other bacterial fish pathogens. We have further 
characterized these metabolites by gas chromatography 
mass spectrometry (GC-MS).  
 
 
MATERIAL AND METHODS 
 
Isolation and screening of marine bacteria 
 
Different marine fishes with visible symptoms of hemorrhage and 
lesions on their body parts were selected; infected regions such as 
mouth, fins and gills were washed under sterile conditions with 
sterile deionized double distilled water and swabbed with sterile 
cotton wool. Suspension of this swab was prepared in saline and 
used for isolation of pathogenic bacteria on nutrient agar plates by 





The colony characteristics of the selected bacterial isolate; size, 
shape, colour, margin, elevation, consistency and opacity were 
observed and recorded. The selected bacterial isolate was gram 
stained and observed under the light microscope at 100 x magni-
fication to study the cell morphology. 
 
 
Identification of test bacterium using biochemical tests 
 
Hi-Media (India) kit for biochemical tests was used to tentatively 
identify this bacterial isolate and results were interpreted according 






Further confirmation of genus and species of the test bacterium 
was done by 16S rDNA sequencing and NCBI–BLAST search 
(Altschul et al., 1990). The genomic DNA was extracted from the 
bacterial isolates and used as template for polymerase chain 
reaction (PCR) amplification of the 16S rDNA fragment (1400 bps) 
according to standard procedure (Sambrook et al., 1989). The 
following eubacterial primers were used for PCR amplification: 
 
27 f (5’- AGAGTTTGATCCTGGCTCAG -3’)  
1492 r (5’- GGTTACCTTGTTACGACTT -3’)  
 
These primers were purchased from MWG Biotech India Pvt. Ltd., 
Bangalore, India. 




Antibiotic susceptibility test 
 
Overnight grown bacterial suspension (0.1 mL) of indicator 
pathogenic bacteria Acinetobacter sp. strain An2 (Accession no. 
FJ38695), Aeromonas hydrophila strain An4 (accession no. 
FJ386959), Staphylococcus arlettae strain An1 (accession no. 
FJ386956) and Alteromonas aurentia strain SE3 was spread plated 
on Mueller Hinton agar plates; octadiscs (OD-007 and 014 from Hi-
Media, India) containing multiple antibiotics were carefully placed in 
the center of the agar plates and incubated at room temperature 
(27°C) for 24 h. Sensitivity of the individual indicator bacterial 
isolate to a particular antibiotic was determined according to the 
performance standards of antibiotic disc susceptibility test approved 




Preparation of crude cell extract  
 
Ethyl acetate extraction procedure was followed with a slight modifi-
cation to extract antimicrobial metabolites from the test bacterium 
(Wratten et al., 1977). Test organism was grown on sea water 
based yeast extract peptone agar (SYEP) agar. After 48 h, agar 
along with the cells was cut into pieces and suspended into ethyl 
acetate to extract the antibacterial metabolites. Overnight suspend-
sion was decanted followed by centrifugation to get cell free solvent. 
Solvent was subjected to evaporation at 40°C for final recovery of 
crude extract (Ahmed et al., 2008). Simultaneously, 48 h old culture 




Antimicrobial bioassay (agar well diffusion test)  
 
In order to check the antibacterial activity of the cell extract, SYEP 
agar (1.2%) was poured in the plates, small wells of about 6 mm 
diameter were made in the agar plates and bottom of the wells 
were sealed by 0.7% molten SYEP agar (Abraham, 2004). 100 µl 
crude cell extract and cell free supernatant were poured in the wells 
separately and allowed to diffuse in the agar media for four hours. 
Different indicator bacterial strains were spread plated on separate 
SYEP agar plates. Ethyl acetate (100 µl) was used as a control to 
check its inhibitory effect. 
 
 
GC-MS analysis of crude cell extract 
 
Identification of the antibacterial metabolites was done by GC-MS 
analysis; injecting 1 µl of sample into a RTX-5 column (7 m x 0.32 
mm) of GC-MS (model GC-MS-QP-2010 plus) from Shimadzu, 
Japan and Helium (3 ml/min) was used as a carrier gas. The 
following temperature gradient program was used: 75°C for 2 min 
followed by an increase from 75 to 175°C at a rate of 50°C per min 
and finally 7 min at 175°C. The m/z peaks representing mass to 
charge ratio characteristic of the antimicrobial fractions were com-






Morphological and biochemical characterization of 
test bacterium 
 
This bacterial isolate appeared as spherical (2 - 3 mm 
diameter), dark green colonies on  thiosulfate  citrate  bile  
 








Zone of clearance (diameter) of indicator bacteria 
Acinetobacter 










Amicacin- (Ak) 10  7 7 3 0 
Carbenicillin- (Cb) 100 5 5 4.5 3 
Ciprofloxacin- (Cf)10 4 4 0 0 
Co-Trimazine- (Cm) 25 9 9 6 6 
Kanamycine– (K) 30 6 6 10 11 
Nitrofurontoin- (Nf) 300 7 7 0 0 
Streptomycin- (S) 10 14 14 6 10 
Tetracycline- (T) 30 14 14 2 1 
Ampicillin- (A) 10 0 0 14 0 
Cephalothin- (Ch) 5 0 0 13 3 
Colistin methane sulphonate- (Cl) 25 1 1 7 9 
Gentamycin- (G) 10 7 7 0 0 
Streptomycin- (S) 10 5 5 2 3.5 
Sulphatriad- (SI) 200 7 7 6 3 
Tetracycline- (T) 25 9 9 3 3 
Co-Trimoxazol- (Co)25 12 12 7 7 
Cell free supernatant 0 0 0 0 
Bacterial crude extract 11 10 12 10 




salts sucrose (TCBS) agar. Biochemical tests revealed 
that this motile bacteria exhibited positive activity for 
oxidase, gelatinase, arginine dihydrolase and lysine 
decarboxylase enzymes, whereas negative activity for o-
nitrophenyl-β-d-galactopyranoside (ONPG), Voges-
Proskauer (VP) and urease enzyme. On triple sugar iron 
(TSI) slant, it showed alkaline slant and acidic butt. Based 
on specific biochemical and morphological characters 
and as per Bergey’s manual of systematic bacteriology, 
this fish pathogenic bacterial strain was tentatively identi-
fied as Vibrio sp.  
PCR amplification of ribosomal gene encoding 16S 
rDNA followed by DNA sequencing and Basic Local 
Alignment Search Tool (BLAST) search clearly confirmed 
the identity of this bacterial pathogen as V. 
parahaemolyticus. Subsequently, we designated this 
pathogenic isolate as V. parahaemolyticus strain AN3 
(Accession No. FJ386958). We have also confirmed 
presence of tdh gene (amplicon size: 264 bp), characte-
ristically encoding thermostable direct hemolysin in V. 
parahaemolyticus (Data not shown). 
 
 
Antibiotic susceptibility test for the indicator bacteria 
 
All indicator bacterial strains exhibited significant suscep-
tibility to majority of common antibiotics tested and were 
also resistant to few antibiotics (Table 1). 
Antibacterial activity of the crude cell extract of the 
test organism 
 
Agar well diffusion experiment clearly demonstrated the 
antagonistic characteristic of crude cell extract of V. 
parahaemolyticus strain AN3 as manifested by growth 
inhibition of gram (-ve) indicator bacteria; Acinetobacter 
sp. strain An 2, Aeromonas hydrophila strain An4, 
Alteromonas aurentia strain SE 3, and gram (+ve) S. 
arlettae strain An1. Interestingly, ethyl acetate cell extract 
of V. parahaemolyticus strain AN3 caused remarkably 
wider inhibitory zones as compared to most of the 
common antibiotics tested. Interestingly, cell free super-
natant as well as ethyl acetate (control) was unable to 
show any inhibitory effect on the growth of indicator 
bacteria. This clearly revealed that these antibacterial 
organic metabolites are present inside the cells of V. 
parahaemolyticus strain AN3 without being secreted out 
(Figures 1a, b, c, d and Table 1). 
 
 
GC-MS analysis of the crude cell extract 
 
GC-MS analysis of crude ethyl acetate cell extract of V. 
parahaemolyticus strain AN3 clearly revealed the 
presence of several important antimicrobial organic meta-
bolites which included indole, phenyl acetic acid, N-(3-
methyl-1,2,4-oxadiazol-5-yl)-1-pyrrolidine, carboximidamide,  
 






Figure 1. Antibacterial activity of the crude cell extract of the V. parahaemolyticus strain An3 
on indicator bacteria. a. S. arlettae strain An1; b. Acinetobacter sp. strain An2, c. A. 
hydrophila strain An 4; d. A. aurentia strain SE3; C, Control (ethyl acetate); CE, cell extract; 




pyrrolopyrazines, tetramethyl pyrazine and other phenolic 





Marine microorganisms including bacteria, fungi and 
microalgae have received increasing attention during 
past few years due to increasing re-isolation of previously 
discovered compounds. Novel and unique structures of 
the secondary metabolites produced by marine organi-
sms also have forced researchers to view the marine 
environment from different perspective and marine 
microorganisms as new biomedical sources. Until now, 
more extensive and focussed efforts to discover new 
antibiotics have involved the terrestrial environment 
mainly due to ease of availability, isolation and culture 
conditions. By the end of 2008, approximately 3000 
microbial metabolites were reported from marine environ-
ment (Rahman et al., 2010).  
GC-MS analysis of crude ethyl acetate cell extract of V. 
parahaemolyticus strain An3 demonstrated an interesting 
concoction of compounds with significant antimicrobial 
activity. A well known antagonistic compound has already 
been reported from V. parahaemolyticus as Vibrindole A, 
a bis-indole derivative (Bell et al., 1994) along with other 
indole derivatives (Kobayashi et al., 1994; Velury et al., 
2003). In addition, other metabolites such as phenyl 
acetic acid, pyrrolidine carboximidamide, pyrrolopyrazines, 
tetramethyl pyrazine and phenolic compounds are also 
well known antimicrobials tested against different bacteria, 
fungi and other microbes (Kim et al., 2004; Somers et al., 
2005; Chaudhary et al., 2006; Kumar et al., 2008; 
Farzaliev et al., 2009; Roy et al., 2010). 
 






Figure 2. Structure and GC-MS spectrum of major antibacterial metabolites present in crude cell extract of V. 
parahaemolyticus strain An3: a. indole (Peak 117); b. phenyl acetic acid (Peak 91); c. N-(3-methyl-1,2,4-oxadiazol-5-yl)-1-
pyrrolidinecarboximidamide (Peak 70); d. pyrrolo- (1,2-a)pyrazine-1,4- dione hexahydro-3(2-methylpropyl)(Peak 70); e. 




Currently, the treatment of infections is compromised 
worldwide by the emergence of multi-drug resistant 
bacteria. In general, bacteria have the genetic ability to 
transmit and acquire resistance to drugs used as thera-
peutic agents. One way to prevent antibiotic resistance is 
by using new compounds which are not based on existing  
 










Table 2. Major antibacterial metabolites present in ethyl acetate cell extract of V. parahaemolyticus strain An3.  
 
Antibacterial metabolite Retention time (mins) % in test volume 
Indole 9.842 3.0 
Phenyl acetic acid 9.3 2.0 
N-(3-methyl-1,2,4-oxadiazol-5-yl)-1-Pyrrolidinecarboximidamide 19.75 1.86 
Pyrrolo-(1,2-a)pyrazine-1,4- dione, hexahydro-3(2-methylpropyl) 20. 033 1.3 
Phenol, 4- (1,1,3,3-tetramethyl butyl) 15.425 0.76 
Nonyl-phenol 16.492 0.6 




synthetic antimicrobial compounds. In the present investi-
gation, we have tried to explore the production of novel 
antimicrobials in order to prevent antibiotic resistance in 
pathogenic bacteria.  
Our primary interest should be practical management 
and control of infectious pathogens in newly developed 
aquaculture sites and human infections. It is interesting to 
note that even pathogenic strains can be used as 
biocontrol agents against other pathogens due to the 
inherent presence of antimicrobial compounds in the form 
of secondary metabolites. Thus antibacterial metabolites 
synthesized by the test organism may serve as source  of  
 




valuable antimicrobial drugs to control pathogenic bacterial 
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